242 related articles for article (PubMed ID: 35663229)
21. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery.
Shadbad MA; Asadzadeh Z; Derakhshani A; Hosseinkhani N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Brunetti O; Argentiero A; Racanelli V; Silvestris N; Baradaran B
Biomed Pharmacother; 2021 Nov; 143():112213. PubMed ID: 34560556
[TBL] [Abstract][Full Text] [Related]
22. The Mechanism of miR-155/miR-15b Axis Contributed to Apoptosis of CD34+ Cells by Upregulation of PD-L1 in Myelodysplastic Syndromes.
Cao M; Peng B; Xu W; Chen P; Li H; Cheng Y; Chen H; Ye L; Xie J; Wang H; Ren L; Xiong L; Zhu J; Xu X; Geng L; Gong S
Mediterr J Hematol Infect Dis; 2023; 15(1):e2023040. PubMed ID: 37435035
[TBL] [Abstract][Full Text] [Related]
23. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
Wang C; Li X; Zhang L; Chen Y; Dong R; Zhang J; Zhao J; Guo X; Yang G; Li Y; Gu C; Xi Q; Zhang R
Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485
[TBL] [Abstract][Full Text] [Related]
24. CircZNF609 enhances hepatocellular carcinoma cell proliferation, metastasis, and stemness by activating the Hedgehog pathway through the regulation of miR-15a-5p/15b-5p and GLI2 expressions.
He Y; Huang H; Jin L; Zhang F; Zeng M; Wei L; Tang S; Chen D; Wang W
Cell Death Dis; 2020 May; 11(5):358. PubMed ID: 32398664
[TBL] [Abstract][Full Text] [Related]
25. MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint.
Tao Z; Xu S; Ruan H; Wang T; Song W; Qian L; Chen K
Cell Physiol Biochem; 2018; 48(2):801-814. PubMed ID: 30032144
[TBL] [Abstract][Full Text] [Related]
26. MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR.
Yang J; Liu R; Deng Y; Qian J; Lu Z; Wang Y; Zhang D; Luo F; Chu Y
Int J Cancer; 2017 Nov; 141(10):2082-2092. PubMed ID: 28758198
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance.
Dondero A; Pastorino F; Della Chiesa M; Corrias MV; Morandi F; Pistoia V; Olive D; Bellora F; Locatelli F; Castellano A; Moretta L; Moretta A; Bottino C; Castriconi R
Oncoimmunology; 2016; 5(1):e1064578. PubMed ID: 26942080
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of circZMIZ1 enhances the anti-tumor activity of CD8
Li X; Wu A; Wang Y; Li D; Wu M
Funct Integr Genomics; 2024 Feb; 24(1):27. PubMed ID: 38332346
[TBL] [Abstract][Full Text] [Related]
29. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations.
Fabian KP; Padget MR; Donahue RN; Solocinski K; Robbins Y; Allen CT; Lee JH; Rabizadeh S; Soon-Shiong P; Schlom J; Hodge JW
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439799
[TBL] [Abstract][Full Text] [Related]
30. MiR-10b-5p Impairs TET2-Mediated Inhibition of PD-L1 Transcription Thus Promoting Immune Evasion and Tumor Progression in Glioblastoma.
Du W; Chen D; Wei K; Yu D; Gan Z; Xu G; Yao G
Tohoku J Exp Med; 2023 Jul; 260(3):205-214. PubMed ID: 37019647
[TBL] [Abstract][Full Text] [Related]
31. Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion.
Alvarez M; Simonetta F; Baker J; Morrison AR; Wenokur AS; Pierini A; Berraondo P; Negrin RS
Front Immunol; 2020; 11():7. PubMed ID: 32117218
[TBL] [Abstract][Full Text] [Related]
32. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
[TBL] [Abstract][Full Text] [Related]
33. Upregulated lncRNA small nucleolar RNA host gene 1 promotes 1-methyl-4-phenylpyridinium ion-induced cytotoxicity and reactive oxygen species production through miR-15b-5p/GSK3β axis in human dopaminergic SH-SY5Y cells.
Xie N; Qi J; Li S; Deng J; Chen Y; Lian Y
J Cell Biochem; 2019 Apr; 120(4):5790-5801. PubMed ID: 30302821
[TBL] [Abstract][Full Text] [Related]
34. miR-4759 suppresses breast cancer through immune checkpoint blockade.
Lin YZ; Liu SH; Wu WR; Shen YC; Wang YL; Liao CC; Lin PL; Chang H; Liu LC; Cheng WC; Wang SC
Comput Struct Biotechnol J; 2022; 20():241-251. PubMed ID: 35024096
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3
Zhu J; Xu X; Liang Y; Zhu R
Biomed Res Int; 2021; 2021():8814862. PubMed ID: 33506036
[TBL] [Abstract][Full Text] [Related]
36. Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.
Kao SC; Cheng YY; Williams M; Kirschner MB; Madore J; Lum T; Sarun KH; Linton A; McCaughan B; Klebe S; van Zandwijk N; Scolyer RA; Boyer MJ; Cooper WA; Reid G
J Thorac Oncol; 2017 Sep; 12(9):1421-1433. PubMed ID: 28629895
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow-derived mesenchymal stem cells inhibit CD8
Liu Z; Mi F; Han M; Tian M; Deng L; Meng N; Luo J; Fu R
Clin Exp Immunol; 2021 Jul; 205(1):53-62. PubMed ID: 33735518
[TBL] [Abstract][Full Text] [Related]
38. GD2 redirected CAR T and activated NK-cell-mediated secretion of IFNγ overcomes MYCN-dependent IDO1 inhibition, contributing to neuroblastoma cell immune escape.
Caforio M; Sorino C; Caruana I; Weber G; Camera A; Cifaldi L; De Angelis B; Del Bufalo F; Vitale A; Goffredo BM; De Vito R; Fruci D; Quintarelli C; Fanciulli M; Locatelli F; Folgiero V
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737337
[TBL] [Abstract][Full Text] [Related]
39. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer.
Mekky RY; Ragab MF; Manie T; Attia AA; Youness RA
Transl Oncol; 2023 May; 31():101653. PubMed ID: 36907052
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B/HOXC4/PD-L1 Axis.
Liu L; Yu T; Jin Y; Mai W; Zhou J; Zhao C
Front Cell Dev Biol; 2021; 9():629893. PubMed ID: 33732698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
